Intestinal permeability and its relevance for absorption and elimination
Data up to Jan 2025
Total Citations Per Year
Abstract
References (194)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
2001 • 16,438 citations
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.
1995 • 5,050 citations
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
1976 • 3,228 citations
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.
1987 • 2,788 citations
Colonic Health: Fermentation and Short Chain Fatty Acids
2006 • 2,522 citations
Drug Metabolism and Disposition
2014 • 2,466 citations
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 • 1,642 citations
Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System
2005 • 1,348 citations
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
1999 • 911 citations
Role of P-Glycoprotein in Pharmacokinetics
2003 • 897 citations
Overview of gut flora and probiotics
1998 • 879 citations
Multiple molecular mechanisms for multidrug resistance transporters
2007 • 831 citations
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.
1997 • 767 citations
Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
1977 • 753 citations
Active outward transport of daunomycin in resistant ehrlich ascites tumor cells
1973 • 729 citations
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*
1997 • 675 citations
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
1999 • 585 citations
Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines
2007 • 574 citations
Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling
2007 • 567 citations
Molecular and Integrative Physiology of Intestinal Peptide Transport
2004 • 538 citations
The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
2004 • 527 citations
Mass transport Phenomena and Models: Theoretical Concepts
1974 • 516 citations
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
2007 • 510 citations
Human Intestinal Permeability
1998 • 493 citations
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology
2004 • 459 citations
Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918
2002 • 452 citations
Correlation of Human Jejunal Permeability (in Vivo) of Drugs with Experimentally and Theoretically Derived Parameters. A Multivariate Data Analysis Approach
1998 • 436 citations
Comparison between permeability coefficients in rat and human jejunum.
1996 • 421 citations
Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.
2002 • 406 citations
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin*
1998 • 404 citations
Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans
2007 • 400 citations
Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model
2006 • 371 citations
The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons.
1995 • 366 citations
Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells
2006 • 360 citations
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*
1995 • 342 citations
Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development
2003 • 306 citations
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
2002 • 303 citations
Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction
1997 • 299 citations
Drug–drug interaction mediated by inhibition and induction of P-glycoprotein
2003 • 296 citations
Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*
1997 • 266 citations
Introduction to intestinal microecology
1972 • 265 citations
Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules
2006 • 257 citations
Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat
1998 • 256 citations
Measurements of Intestinal Permeability Using Low Molecular Weight Polyethylene Glycols (PEG 400)
1977 • 243 citations
The drug efflux–metabolism alliance: biochemical aspects
2001 • 230 citations
Regional rectal perfusion: a new in vivo approach to study rectal drug absorption in man.
1995 • 225 citations
Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation
1996 • 221 citations
Absorption Potential: Estimating the Fraction Absorbed for Orally Administered Compounds
1985 • 218 citations
ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
2003 • 217 citations
Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
1998 • 216 citations
The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension
2005 • 215 citations
Keynote review: Intestinal Peyer's patch M cells and oral vaccine targeting
2005 • 213 citations
Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation
1977 • 209 citations
Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models
1997 • 209 citations
Gene and Protein Expression of P-Glycoprotein, MRP1, MRP2, and CYP3A4 in the Small and Large Human Intestine
2007 • 206 citations
Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract
2005 • 194 citations
Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: Comparison between human segments and Caco-2 cells
2006 • 193 citations
Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400.
1977 • 189 citations
Transport of celiprolol across human intestinal epithelial (Caco‐2) cells: mediation of secretion by multiple transporters including P‐glycoprotein
1993 • 178 citations
Untitled
1992 • 173 citations
Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.
1991 • 171 citations
Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans.
1997 • 169 citations
Species Differences in Size Discrimination in the Paracellular Pathway Reflected by Oral Bioavailability of Poly(ethylene glycol) and d-Peptides
1998 • 169 citations
The pivotal role of hepatocytes in drug discovery
2006 • 165 citations
Pharmacokinetics and metabolism in early drug discovery
1999 • 160 citations
Clinical Relevance of P-Glycoprotein in Drug Therapy
2003 • 159 citations
SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers
2007 • 158 citations
In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model
2003 • 157 citations
Effect of gastrointestinal intubation on the passage of a solid meal through the stomach and small intestine in humans
1983 • 156 citations
P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans
2003 • 156 citations
Intestinal Microflora: Metabolism of Drugs and Carcinogens
1990 • 150 citations
Modulation of oral bioavailability of anticancer drugs: from mouse to man
2000 • 147 citations
Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
2001 • 146 citations
Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo
2007 • 141 citations
Efflux transporters in ulcerative colitis
2006 • 140 citations
Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
1999 • 139 citations
St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism*1
2004 • 137 citations
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
2008 • 137 citations
Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
2002 • 134 citations
Tacrolimus is a class II low-solubility high-permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats
2002 • 133 citations
Intestinal Drug Transporters: In Vivo Function and Clinical Importance
2004 • 132 citations
Measurements of Intestinal Permeability Using Low Molecular Weight Polyethylene Glycols (PEG 400)
1977 • 131 citations
Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas
2002 • 130 citations
Transport Characteristics of Fexofenadine in the Caco-2 Cell Model
2004 • 129 citations
Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity
2007 • 129 citations
Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol
2007 • 128 citations
Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.
1989 • 126 citations
Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers
1998 • 125 citations
In Vitro–In Vivo Correlation of Hepatobiliary Drug Clearance in Humans
2007 • 116 citations
Development of a new engineering-based capsule for human drug absorption studies
2000 • 116 citations
The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.
1993 • 112 citations
Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability
2002 • 111 citations
Interactions of Human P-glycoprotein with Simvastatin, Simvastatin Acid, and Atorvastatin
2004 • 111 citations
A New Principle for Tight Junction Modulation Based on Occludin Peptides
2003 • 111 citations
Improvement of Oral Drug Treatment by Temporary Inhibition of Drug Transporters and/or Cytochrome P450 in the Gastrointestinal Tract and Liver: An Overview
2002 • 109 citations
Gastric Emptying: Comparison of Scintigraphic, Polyethylene Glycol Dilution, and Paracetamol Tracer Assessment Techniques
2000 • 109 citations
Differential Substrate and Inhibitory Activities of Ranitidine and Famotidine toward Human Organic Cation Transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
2005 • 109 citations
Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein
2002 • 107 citations
A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans
2001 • 105 citations
Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?
1995 • 104 citations
Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.
2003 • 102 citations
Kinetic Considerations for the Quantitative Assessment of Efflux Activity and Inhibition: Implications for Understanding and Predicting the Effects of Efflux Inhibition
2006 • 101 citations
Jejunal absorption and metabolism of R/S-verapamil in humans.
1998 • 99 citations
Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate.
1997 • 98 citations
Innovative Methods to Study Human Intestinal Drug Metabolism in Vitro: Precision-Cut Slices Compared with Ussing Chamber Preparations
2006 • 98 citations
Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat.
1994 • 97 citations
The Method of Intraluminal Perfusion of the Human Small Intestine
1973 • 97 citations
Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil*
1999 • 95 citations
Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms
1997 • 93 citations
Region-Dependent Modulation of Intestinal Permeability by Drug Efflux Transporters: In Vitro Studies in mdr1a(−/−) Mouse Intestine
2002 • 93 citations
Determination of intrinsic membrane transport parameters from perfused intestine experiments: A boundary layer approach to estimating the aqueous and unbiased membrane permeabilities
1988 • 93 citations
Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique
2001 • 90 citations
Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine,
2003 • 88 citations
Bioavailability and pharmacokinetics of cimetidine
1979 • 87 citations
Controlled release technologies for drug delivery
2003 • 87 citations
Taxol transport by human intestinal epithelial Caco-2 cells.
1998 • 85 citations
Jejunal permeability in humans invivo and rats insitu: investigation of molecular size selectivity and solvent drag
1999 • 82 citations
CYP3A4, CYP3A5, and MDR1 in Human Small and Large Intestinal Cell Llines Suitable for Drug Transport Studies
2001 • 80 citations
Discussion
1998 • 80 citations
The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique
2002 • 79 citations
Differential absorption of amoxicillin from the human small and large intestine
1994 • 76 citations
The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)‐verapamil in humans
1999 • 76 citations
Jejunal permeability and hepatic extraction of fluvastatin in humans
1996 • 75 citations
Hepatic clearance of drugs. III. Additional experimental evidence supporting the “wellstirred” model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liverin situ preparation
1977 • 75 citations
The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique
2003 • 74 citations
Interactions in the renal and biliary elimination of digoxin: Stereoselective difference between quinine and quinidine
1990 • 74 citations
Variable expression of CYP and Pgp genes in the human small intestine
2003 • 74 citations
Site-dependent small intestinal absorption of ranitidine
1994 • 73 citations
Increased??Absorption??of??Digoxin from??the??Human??Jejunum Due??to??Inhibition??of??Intestinal Transporter-Mediated Efflux
2007 • 71 citations
Digoxin-verapamil interaction: Reduction of biliary but not renal digoxin clearance in humans
1991 • 70 citations
Nonlinearity of amoxicillin absorption kinetics in human
1992 • 64 citations
Molecular and Pharmacokinetic Properties of 222 Commercially Available Oral Drugs in Humans.
2001 • 64 citations
Dependence of intestinal absorption in vivo on the unstirred layer
1978 • 64 citations
Pharmacokinetics of gefitinib in humans: The influence of gastrointestinal factors
2007 • 63 citations
Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase
2006 • 62 citations
Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut
2001 • 61 citations
Quinidine reduces biliary clearance of digoxin in man
1987 • 61 citations
Human jejunal permeability of two polar drugs: cimetidine and ranitidine.
2001 • 59 citations
Intestinal Absorptive Transport of the Hydrophilic Cation Ranitidine: A Kinetic Modeling Approach to Elucidate the Role of Uptake and Efflux Transporters and Paracellular vs. Transcellular Transport in Caco-2 Cells
2006 • 58 citations
Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion.
1997 • 57 citations
Inhibition of Human Intestinal Wall Metabolism by Macrolide Antibiotics: Effect of Clarithromycin on Cytochrome P450 3A4/5 Activity and Expression*
2005 • 57 citations
The Site-Specific Transport and Metabolism of Tacrolimus in Rat Small Intestine
2003 • 57 citations
The Absence of Stereoselective P-Glycoprotein-mediated Transport of R/S-Verapamil Across the Rat Jejunum
1998 • 54 citations
Presentation of a Structurally Diverse and Commercially Available Drug Data Set for Correlation and Benchmarking Studies
2006 • 53 citations
Pharmacokinetics of felodipine in patients with liver disease
1989 • 53 citations
Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
1991 • 53 citations
Resolution of P‐glycoprotein and non‐P‐glycoprotein effects on drug permeability using intestinal tissues from mdr1a (−/−) mice
2002 • 51 citations
Carrier-mediated jejunal absorption of conjugated bile acids in the guinea pig
1996 • 51 citations
The Lack of Effect of Induced Net Fluid Absorption on thein vivoPermeability of Terbutaline in the Human Jejunum
1995 • 46 citations
Comparison of Furosemide and Vinblastine Secretion from Cell Lines Overexpressing Multidrug Resistance Protein (P-Glycoprotein) and Multidrug Resistance-Associated Proteins (MRP1 and MRP2)
2002 • 45 citations
Involvement of Breast Cancer Resistance Protein (BCRP/ABCG2) in the Biliary Excretion and Intestinal Efflux of Troglitazone Sulfate, the Major Metabolite of Troglitazone with a Cholestatic Effect
2006 • 45 citations
FIRST-PASS EFFECTS OF VERAPAMIL ON THE INTESTINAL ABSORPTION AND LIVER DISPOSITION OF FEXOFENADINE IN THE PORCINE MODEL
2006 • 45 citations
The permeability coefficient of the wall of a villous membrane
1978 • 44 citations
A Residence-Time Distribution Analysis of the Hydrodynamics within the Intestine in Man during a Regional Single-pass Perfusion with Loc-I-Gut: In-vivo Permeability Estimation
1997 • 43 citations
Paracetamol absorption from different sites in the human small intestine.
1994 • 42 citations
CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs
1999 • 42 citations
Comparison of P-glycoprotein-mediated drug–digoxin interactions in Caco-2 with human and rodent intestine: Relevance to in vivo prediction
2005 • 41 citations
Optimising drug development: strategies to assess drug metabolism/transporter interaction potential — towards a consensus
2001 • 40 citations
Regional Intestinal Absorption and Biliary Excretion of Fluvastatin in the Rat: Possible Involvement of mrp2
2004 • 40 citations
Saturable Absorptive Transport of the Hydrophilic Organic Cation Ranitidine in Caco-2 Cells: Role of pH-Dependent Organic Cation Uptake System and P-Glycoprotein
2006 • 40 citations
Contributions of Saturable Active Secretion, Passive Transcellular, and Paracellular Diffusion to the Overall Transport of Furosemide Across Adenocarcinoma (Caco-2) Cells
2002 • 40 citations
The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum.
1994 • 39 citations
The Biopharmaceutic Drug Classification and Drugs Administered in Extended Release (Er) Formulations
1997 • 39 citations
Griseofulvin absorption from different sites in the human small intestine
1994 • 37 citations
Influence of morphometric factors on quantitation of paracellular permeability of intestinal epithelia in vitro.
1997 • 37 citations
Delivery aspects of small peptides and substrates for peptide transporters
2005 • 37 citations
The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans
2002 • 36 citations
The influence of gastrointestinal transit on drug absorption in healthy volunteers.
1992 • 34 citations
HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
2004 • 33 citations
Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats.
1997 • 32 citations
A Perfusion Bioreactor for Intestinal Tissue Engineering
2007 • 32 citations
Transporter-mediated Intestinal Absorption of Fexofenadine in Rats
2006 • 31 citations
Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats.
1999 • 30 citations
Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers
2006 • 29 citations
Folate absorption from folate-fortified and processed foods using a human ileostomy model
2006 • 29 citations
Intestinal drug absorption and bioavailability: beyond involvement of single transport function
2003 • 28 citations
Systemic Availability of the Active Metabolite Hydroxy‐Fasudil After Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract
2006 • 28 citations
Enantiomeric separation of verapamil and norverapamil using Chiral-AGP® as the stationary phase
1999 • 27 citations
Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine
2003 • 27 citations
Digoxin-interactions in man: Spironolactone reduces renal but not biliary digoxin clearance
1992 • 26 citations
A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: Experiences from 13 phase I studies
2007 • 24 citations
Dose-dependent absorption of amoxicillin in patients with an ileostomy
1992 • 23 citations
The Method of Intraluminal Perfusion of the Human Small Intestine
1973 • 23 citations
Effects of a non‐absorbable osmotic load on drug absorption in healthy volunteers.
1992 • 22 citations
Inhibition by basic drugs of digoxin secretion into human bile
1992 • 19 citations
Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
1989 • 19 citations
Absorption profiles for polyethylene glycols after regional jejunal perfusion and oral load in healthy humans.
1997 • 19 citations
Stereoselective Inhibition by the Diastereomers Quinidine and Quinine of Uptake of Cardiac Glycosides into Isolated Rat Hepatocytes
1998 • 13 citations
The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides
1998 • 13 citations
Investigations of the In-vitro Metabolism of Three Opioid Tetrapeptides by Pancreatic and Intestinal Enzymes
2000 • 13 citations
No effect of probenecid on the renal and biliary clearances of digoxin in man.
1991 • 9 citations
Intestinal Absorption of Amiodarone in Man
1990 • 9 citations
EUFEPS conference on Drug Transporters at Copenhagen: Integrative approaches in ADME research
2005 • 7 citations
The Method of Intraluminal Perfusion of the Human Small Intestine
1973 • 6 citations